Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?


KILIÇKAP S., DEMİRKAZIK A., GÜRSOY P. , DEMİRCİ U., ERMAN M., YUMUK P. F. , ...Daha Fazla

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019